Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS Travere Therapeutics, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients…
Genialis Supermodel Predicts Patient Response to HER2-Targeted Therapy Enhertu Genialis, the therapeutic intelligence company, announced it will present the first results from a new AI-based algorithm designed to distinguish between patients more likely to benefit from treatment with trastuzumab deruxtecan (Enhertu®, T-DXd).…
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to enhance…
Quiver Bioscience Receives Strategic Investment From the Porta Family to Advance UBE3A ASO Therapeutic Program for Dup15q Syndrome Quiver Bioscience a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system (CNS) disorders, today announced…
Transcat Expands into Latin America with Acquisition of SCM Metrology and Laboratories S.A. Transcat, Inc. a leading provider of test measurement, control and calibration, announced the acquisition of SCM Metrology and Laboratories S.A. (“SCM”), a privately-held calibration services provider based…
Emalex Receives U.S. Patent for Orally Disintegrating Ecopipam Formulation Emalex Biosciences announced that the U.S. Patent and Trademark Office issued a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an investigational D1 receptor antagonist in development for the…
ADDING MULTIMEDIA Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces today the appointment of Christoph Korpus, PhD, MBA, as Chief Executive Officer (CEO), effective…
Booz Allen Advances Orbital Warfare for Space Domain Booz Allen Hamilton announced that its corporate venture capital arm, Booz Allen Ventures, has invested in Portal Space Systems, a U.S.-based space technology company developing rapidly maneuverable spacecraft for next-generation orbital operations. Portal Space Systems…
GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system GE HealthCare integrates bkActiv™ with the Medtronic Stealth AXiS™ surgical navigation system, which is now commercially available to provide real-time advanced imaging during…
Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS Coya Therapeutics, Inc. a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the…
Cartherics and Catalent Expand Commercial License Agreement Cartherics Pty Ltd, a biotechnology company developing off‑the‑shelf immune cell therapies for high‑impact women’s diseases, including ovarian cancer and endometriosis, and Catalent, Inc., the leader in enabling the development and supply of better…
Chevron Confirms Oil Discovery at Bandit Prospect in Gulf of America Chevron Corporation confirmed an oil discovery at the Bandit prospect in the Gulf of America, as announced by operator Occidental. The exploration well is located in Green Canyon Block…